Home » Topics » BioWorld Science

BioWorld Science
RSS

Broadly neutralizing HCV antibodies isolated from high responders used to design new antibody

Feb. 18, 2022

Neurophilin-1 is an inhibitor of HIV-1 infectivity

Feb. 18, 2022

New HSD17B13 inhibitors identified at Inipharm

Feb. 18, 2022

Fog Pharmaceuticals describes stapled peptides targeting beta-catenin

Feb. 18, 2022

New SREBP inhibitors identified at Capulus Therapeutics

Feb. 18, 2022

Merck & Co. presents new adenosine A2A and/or A2B receptor antagonists

Feb. 18, 2022

New coagulation factor XIa inhibitors synthesized at Janssen Pharmaceutica

Feb. 18, 2022

Monoclonal antibodies in AR-701 cocktail neutralize SARS-CoV-2 Omicron variant

Feb. 18, 2022

Neumora licenses rights to novel M4 receptor PAMs from Vanderbilt for schizophrenia

Feb. 18, 2022

CECR2 promotes breast cancer metastasis through NF-kappaB signaling and immunosuppression

Feb. 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...